Obinutuzumab is a potent anti-B cell drug already approved to treat lupus nephritis, chronic lymphocytic leukemia, and follicular lymphoma. Therapies targeting B cells are perhaps the most effective ...
Obinutuzumab, a glycoengineered type II anti-CD20 monoclonal antibody, induces potent B-cell depletion and is approved for the treatment of active lupus nephritis. Its efficacy and safety in patients ...
8 Lions Entertainment, the specialist digital studio focused on scaling IP on YouTube, has partnered with Lupus Films, a UK independent animation studio, to launch, manage and grow the global YouTube ...
8 Lions Entertainment has partnered with Lupus Films to launch, manage and grow the global YouTube presence of the preschool animated series The Hive. As part of the rollout, 8 Lions will launch and ...
“USA250: The Story of the World’s Greatest Economy” is a yearlong WSJ series examining America’s first 250 years. Read more about it from Editor in Chief Emma Tucker. America has officially been in ...
LOS ANGELES (KABC) -- For decades, treatments for lupus, which affects 1.5 million Americans, have been few and far between. The condition affects mainly women and can be debilitating. Now, a ...
Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2 trial for discoid lupus ...
Everyone knows it’s hard to get college students to do the reading—remember books? But the attention-span crisis is not limited to the written word. Professors are now finding that they can’t even get ...
On a special 2025 wrap-up podcast, The Film Stage co-founder and editor-in-chief Jordan Raup is joined by managing editor and Emulsion host Nick Newman and The B-Side co-host Conor O’Donnell to ...
As 2025 comes to a close, the biggest movies of the year are now available to stream from home — quite literally. Disney’s “Lilo & Stitch” is available on Disney+ after earning more than $1 billion at ...
Every year, the awards gods decree that a certain group of films are the most noteworthy. Many of the same titles end up appearing on every list of critics association awards, guild nominations and ...